# The Use of Anti-CD4 Monoclonal Antibody (mAb)-Fragment for the Imaging of Chronic Inflammation in Patients With Active Rheumatoid Arthritis

> **NCT00372177** · PHASE1,PHASE2 · COMPLETED · sponsor: **Biotectid GmbH** · enrollment: 5 (actual)

## Conditions studied

- Rheumatoid Arthritis
- Polyarthritis
- Rheumatism
- Autoimmune Disease
- Inflammation

## Interventions

- **RADIATION:** Fab-fragment of Anti-human CD4

## Key facts

- **NCT ID:** NCT00372177
- **Lead sponsor:** Biotectid GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2008-05-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00372177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00372177, "The Use of Anti-CD4 Monoclonal Antibody (mAb)-Fragment for the Imaging of Chronic Inflammation in Patients With Active Rheumatoid Arthritis". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00372177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*